Rchr
J-GLOBAL ID:200901064710460970   Update date: Feb. 14, 2024

AKIHIRO INANO

イナノ アキヒロ | AKIHIRO INANO
Affiliation and department:
Job title: Associate Professor
Research field  (1): Clinical pharmacy
Research keywords  (1): Clinical Pharmacology
Research theme for competitive and other funds  (1):
  • 2011 - 2012 NEDO Microdose Project
Papers (26):
  • Takagi H, Zhao S, Muto S, Yokouchi H, Nishihara H, Harada T, Yamaguchi H, Mine H, Watanabe M, Ozaki Y, et al. Delta-like 1 homolog (DLK1) as a possible therapeutic target and its application to radioimmunotherapy using 125I-labelled anti-DLK1 antibody in lung cancer models (HOT1801 and FIGHT004). Lung cancer (Amsterdam, Netherlands). 2021. 153. 134-142
  • Fujii M, Kobayakawa M, Saito K, Inano A, Morita A, Hasegawa M, Mukasa A, Mitsuhara T, Goto T, Yamaguchi S, et al. Rationale and Design of BeatNF2 Trial: A Clinical Trial to Assess the Efficacy and Safety of Bevacizumab in Patients with Neurofibromatosis Type 2 Related Vestibular Schwannoma. Current oncology (Toronto, Ont.). 2021. 28. 1. 726-739
  • Yamada H, Ohira H, Ikegami F, Nakamura K, Takahashi A, Abe K, Inano A, Shimada S, Miyata K, Saito T, et al. Effects of Child-Pugh B Cirrhosis on Pharmacokinetics of Tofogliflozin, a New Sodium-Glucose Co-Transporter (SGLT2) Inhibitor. Drug research. 2020. 70. 9. 401-409
  • Kudo T, Inano A, Midorikawa S, Kubo H, Hayashi K, Nakashima S, Fukushima C, Maeda K, Oriuchi N, Irie S, et al. Determination of the Kinetic Parameters for 123I Uptake by the Thyroid, Thyroid Weights, and Thyroid Volumes in Present-day Healthy Japanese Volunteers. Health physics. 2020. 118. 4. 417-426
  • 鈴木 康裕, 松野 香里, 稲野 彰洋. 抗体医薬品のマイクロドーズ量に関する初回投与量と承認された最小臨床用量からの考察. 臨床薬理. 2020. 51. 1. 1-10
more...
Books (5):
  • 薬剤学実験法 必携マニュアル Pharmaceutical Scientistのために
    その他の出版機関 2014
  • 薬剤学実験法 必携マニュアル Pharmaceutical Scientistのために
    その他の出版機関 2014
  • 治験総括報告書の英訳・和訳の傾向と対策
    メディファーマランゲージ株式会社 2013
  • 治験総括報告書の英訳・和訳の傾向と対策
    メディファーマランゲージ株式会社 2013
  • 臨床研究のための倫理審査ハンドブック
    丸善 2011
Lectures and oral presentations  (1):
  • 試験プロトコルおよびインフォームドコンセント
    (我が国における14C-MD臨床試験の実施手順 2011)
Education (2):
  • 2000 - 2003 Kanazawa University Graduate School, Division of National Science and Technology
  • 1990 - 1995 Toyama Medical and Pharmaceutical University Faculty of Pharmaceutical Science
Professional career (1):
  • 薬学博士 (金沢大学)
※ Researcher’s information displayed in J-GLOBAL is based on the information registered in researchmap. For details, see here.

Return to Previous Page